Accelrys Partners with Three Pharmas to Develop Solution for Registration of Biological Entities
Accelrys said this week that it is collaborating with three pharmaceutical firms to develop a solution for the identification, registration, storage, searching and intellectual property protection of biological entities.
Accelrys said that the collaborative development model allows it to leverage the collective knowledge and expertise of the participants to establish requirements.
Phase one of the collaborative software development effort includes identifying the requirements for the registration of biological entities.
The company said it expects additional pharmas to join the effort in subsequent phases of the collaboration.
Neuromed Pharma to License AurScope from Aureus Pharma
Aureus Pharma, which offers knowledge management solutions to accelerate discovery in the life sciences industry, said this week that Neuromed Pharmaceuticals has licensed its AurScope Ion Channel Knowledge database.
AurSCOPE Ion Channel includes information on biological activity mined from scientific literature.
The database can be used by pharmaceutical researchers to rapidly access prior knowledge related to ion channels for all stages of the drug discovery process, Aureus said in a statement.
Tomy Digital Biology To Distribute Protagen’s Software in Japan
Protagen, which offers services and software solutions for protein research, said this week that it has entered into a distribution agreement for its Bio-IT software product, Modiro – the PTM-Explorer, with Tomy Digital Biology of Tokyo.
The Modiro software, which provides qualitative analysis of post-translational modifications for protein researchers, launched in March.
Through the agreement with Tomy Digital Biology, Protagen said it will gain an established distributor for its product in the Japanese market.
Modiro enables researchers to identify modifications using existing mass-spectrometry data.
InforSense Extends Collaboration With Cambridge University
InforSense said this week that it has extended its relationship with Cambridge University’s Department of Pathology.
The agreement covers the renewal of licenses for the InforSense platform and BioSense, and the addition of new licenses for TextSense for text analytics, and GenSense for genome-wide association study analysis.